RYLEMBRA
Live / Allowed — Notice of allowance issued (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Feb 2020 filing date already counts against anyone who files later.
Record
- Serial number
- 88787818
- Mark type
- Stylized text
- Filed
- 06 Feb 2020
- Published for opposition
- 20 Jan 2026
- Attorney of record
- Cynthia A. Moyer
Goods and services
- Class 001 — Chemicals: Phyto-therapeutic ingredients for use in the manufacture of pharmaceuticals; Phytochemical additives for use in the manufacture of pharmaceutical preparations for use in the pharmaceutical and wellness industry
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of phyto-therapeutic based natural health and wellness preparations for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation, cancer, arthritis, and neurological disorders; Natural health products being medical and wellness products, namely, phyto-therapeutic compounds for use in treating neuropathic diseases and conditions
Owner
- Zyus Life Sciences Inc., Saskatoon, SK, CA
- Zyus Life Sciences Inc., Saskatoon, SK, CA
Prosecution history
- 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
- 20 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 20 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
- 20 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
- 22 Sept 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Sept 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 21 Jun 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 21 Jun 2025 — FINAL REFUSAL E-MAILED
- 21 Jun 2025 — FINAL REFUSAL WRITTEN
- 14 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED